HOLX
Hologic Inc.
Is HOLX Halal?
Historically permissible women's-health medical technology business with passing known ratios; Hologic became private in April 2026.
What You Should Know
Hologic develops diagnostic and medical-imaging systems focused on women's health, a generally permissible medical-technology activity. Its December 27, 2025 Form 10-Q reports assets of $9,180.7 million, debt of $2,508.7 million, cash of $2,168.0 million, short-term investments of $196.7 million, receivables of $584.2 million and quarterly revenue of $1,047.8 million. Debt/assets is 27.33%, liquidity/assets is 25.76%, receivables plus cash/assets is 29.98% and disclosed interest income is $19.7 million, or 1.88% of revenue. Hologic became a private company on April 7, 2026, so these are historical ratios and not a current public-stock recommendation.
⚠️ Concerns
- •Hologic became private on April 7, 2026 and HOLX was delisted
- •Historical known asset-based ratios pass, but no current public market-cap series exists
- •Disclosed interest income is 1.88% of quarterly revenue; no fixed purification percentage asserted
- •Successor-company financing and future disclosures require separate review
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2025-12-27; calculated 2026-07-15.
2,508.7 / 9,180.7
2,364.7 / 9,180.7
2,752.2 / 9,180.7
19.7 / 1,047.8
- Financial
- Pass
- Overall
- Incomplete
Historical debt/assets is 27.33%, liquidity/assets is 25.76%, receivables plus cash/assets is 29.98% and interest income is 1.88%; the examined FTSE ratios pass, but current issuer status is incomplete.
- Financial
- Pass
- Overall
- Incomplete
Historical known asset-based ratios are below the examined MSCI limits; this is not an index-membership claim and HOLX is no longer public.
- Financial
- Pass
- Overall
- Incomplete
Historical known asset ratios are below the examined Malaysia limits; this is not an official classification and does not establish current tradability.
- Financial
- Not calculated
- Overall
- Incomplete
Hologic became private on April 7, 2026, so no current public market-cap series is available.
Business-activity disclosure
Hologic develops diagnostic and medical-imaging systems focused on women's health, a generally permissible medical-technology activity. The April 7, 2026 acquisition took Hologic private, so the filing supports only a historical screen and not current public investability.
Limitation: No current public market-cap series or post-closing private-company filing is available, and the filing does not provide a universal prohibited-revenue numerator.
Purification
Interest income is disclosed at 1.88% of quarterly revenue, but ZakatInvest does not prescribe a fixed scholar-approved purification percentage and HOLX is no longer a public security.
Inputs, assumptions and primary sources
- December 27, 2025 figures are USD millions from Hologic's fiscal Q1 2026 Form 10-Q, the last public-company filing before closing.
- Debt includes current debt of $5.8 million and long-term debt of $2,502.9 million; finance-lease liabilities are excluded. Cash is $2,168.0 million and short-term investments are $196.7 million.
- Accounts receivable are $584.2 million and product plus service/other revenue totals $1,047.8 million.
- The filing reports $19.7 million of interest income, or 1.88% of quarterly revenue.
- Hologic became a private company on April 7, 2026 after the Blackstone/TPG merger and its public shares were delisted; this is a historical screen only.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →